ApaTech steps up US synthetic bone graft drive
This article was originally published in Clinica
Executive Summary
UK synthetic bone graft developer ApaTech is stepping up for the next stage in its own development with the establishment of US operations. The London, UK-based spin-out of Queen Mary University recently obtained FDA 510(k) clearance for its Pore-Si and ApaPore products, and is aiming to "capture significant market share in the US", according to ApaTech Inc's new president, Steve Czick.